Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 22, Issue 4, 1996, Pages 215-229

  Cherukupalli, Kamala ^a   Larson, Janet E ^b   Rotschild, Avi ^c   Thurlbeck, William M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b OCHSNER MEDICAL CENTER   (United States)

^c Ochsner Medical Foundation ^*

Author keywords

barotrauma; Collagen; elastin; hyaline membrane disease; oxygen; prematurity; sudden infant death syndrome

Indexed keywords

COLLAGEN; DESMOSINE; ELASTIN; HYDROXYPROLINE;

ARTICLE; ASSISTED VENTILATION; BAROTRAUMA; DISEASE CLASSIFICATION; DNA CONTENT; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LUNG DYSPLASIA; PREMATURITY; PRIORITY JOURNAL; PROTEIN CONTENT; SUDDEN INFANT DEATH SYNDROME; SURVIVAL;

BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; COLLAGEN; DESMOSINE; DNA; HUMANS; HYALINE MEMBRANE DISEASE; HYDROXYPROLINE; INFANT; INFANT, NEWBORN; LUNG;

EID: 0029951705     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199610)22:4<215::AID-PPUL1>3.0.CO;2-L     Document Type: Article

References (52)

1. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease. N Engl J Med. 1967; 276:357-368.
2. Berg TJ, Paghtakhan RD, Reed MH, Langston C, Chemick V. Bronchopulmonary dysplasia and lung rupture in hyaline membrane disease; influence of continuing distending pressure. Pediatrics. 1975; 55:51-54.
3. Gay JH, Daily WJR, Mayr BHP, Trump DS, Cloud DT, Molthan ME. Ligation of the patent ductus arteriosus in premature infants: report of 45 cases. J Pediatr Surg. 1973; 8:677-683.
4. Stocker JT, Madewell JE. Persistent interstitial pulmonary emphysema: Another complication of the respiratory distress syndrome. Pediatrics. 1977; 59:847-857.
5. Northway WH Jr. Observations on bronchopulmonary dysplasia. J Pediatr. 1979; 95:815-818.
6. Edwards DK. Radiographic aspects of bronchopulmonary dysplasia. J Pediatr. 1979; 95:823-829.
7. Wung JT, Koons AH, Driscoll JM, James LS. Changing incidence of bronchopulmonary dysplasia. J Pediatr. 1979; 95:845-848.
8. Bonikos DS, Bensch KG, Northway WH Jr, Edwards DK. Bronchopulmonary dysplasia: The pulmonary pathological sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol. 1976; 7:643-666.
9. Stocker JT. Pathological features of long-standing 'healed' bronchopulmonary dysplasia. Hum Pathol. 1986; 17:943-961.
10. Taghizadeh A, Reynolds EOR. Pathogenesis of bronchopulmonary dysplasis following hyaline membrane disease. Am J Pathol. 1976; 82:241-263.
11. Edwards DK, Colby TV, Northway WH Jr. Radiographic-pathologic correlation in bronchopulmonary dysplasia. J Pediatr. 1979; 95:834-836.
12. Fujiwara T, Maeta S, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline membrane disease. Lancet. 1980; 1:55-59.
13. Taeusch HW Jr, Clements J, Benson B. Exogenous surfactant for human lung disease. Current status. Am Rev Respir Dis. 1983; 128:791-794.
14. Horbar JD, Wright EC, Ostand L, Members of the National Institute of Child Health and Human Development. Decreasing mortality associated with the introduction of surfactant therapy: An observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics 1993; 92:191-197.
15. Anderson RW, Strickland MB, Tsai SH, Haglin JJ. Light microscopic and ultrastructural study of the adverse effects of oxygen therapy on the neonate lung. Am J Pathol. 1973; 73:327-331.
16. Kapanci Y, Weibel ER, Kaplan HP, Robinson FR. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ultrastructural and morphometric studies. Lab Invest. 1969; 20:101-108.
17. Kotas RV. Barotrauma in the developing lung. In: BPD and Other Related Chronic Respiratory Disorders. Report of the Ninetieth Ross Conference on Pediatric Research. Columbus, OH: Ross Laboratories, 1986:33-41.
18. Pusey VA, Macpherson RI, Chemick V. Pulmonary fibroplasia following prolonged artificial ventilation of newborn infants. Can Med Assoc J. 1969; 100:451-457.
19. Rhodes PG, Hall RT, Leonidas JC. Chronic pulmonary disease in neonates with assisted ventilation. Pediatrics. 1975; 55:788-796.
20. Bateman E, Turner-Warwick M, Adelmann-Grill BC. Immunohistochemical study of collagen types in human fetal lung and fibrotic disease. Thorax. 1981; 36:645-653.
21. Desai R, Wigglesworth JS, Aber V. Assessment of elastin maturation by radioimmunoassay of desmosine in the developing human lung. Early Hum Dev. 1988; 16:61-71.
22. Hislop A, Wigglesworth JS, Desai R, Aber V. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev. 1987; 15:147-164.
23. Keeley FW, Fagan DG, Webster SI. Quantity and character of elastin in developing human lung parenchymal tissues of normal infants and infants with RDS. J Lab Clin Med. 1977; 90:981-989.
24. Wigglesworth JS, Desai R, Aber V. Quantitative aspects of perinatal lung growth. Early Hum Dev. 1987; 15:203-212.
25. Cherukupalli K, Larson JE, Putterman M, Thurlbeck WM. Comparative biochemistry of gestational and postnatal lung growth in the rat and human. Pediatr Pulmonol. (submitted).
26. Bronchopulmonary dysplasia (BPD). In: Guidelines for the Care of Children with Chronic Lung Disease. Bureau of Maternal and Child Health and Resource Development. Pediatr Pulmonol. 1989; 6(suppl 3):3-4.
27. Schmidt G, Thaunhauser SJ. A method for the determination of deoxyribonucleic acid, ribonucleic acid and phosphoproteins in animal tissues. J Biol Chem. 1945; 161:83-89.
28. Wannemacher RW, Banks WL, Wunner WH. Use of a single tissue extract to determine cellular protein and nucleic acid concentrations and rate of amino acid incorporation. Anal Biochem. 1965; 11: 320-326.
29. Laurent GJ, Cockrill P, McAnulty RJ, Hastings JRD. A simplified method for quantitation of the relative amounts of Type 1 and Type III collagen in small tissue samples. Anal Biochem. 1981; 113:301-312.
30. Burton L. Study of conditions and mechanisms of diphenylarnine reaction for colorimetric determination of deoxyribonucleic acid. Biochem. J. 1956; 62:315-323.
31. Lowry OH, Roseborough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol ageant. J Biol Chem. 1951; 193: 265-275.
32. Woessner JF, Jr. Determination of hydroxyproline in connective tissues. In: Hall DA, ed. The Methodology of Connective Tissue Research. Oxford: Joynson-Bruvvers, 1976; 223-227.
33. Harel S, Janoff A, Yu SY. Desmosine radioimmunoassay for measuring elastin degradation in vivo. Am Rev Respir Dis. 1980; 122:769-773.
34. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 1970; 227:680-688.
35. Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest. 1985; 76:1297-1305.
36. Blanco LN, Massaro D, Massaro GD. Alveolar size, number, and surface area: Develomentally dependent response to 13% oxygen. Am J Physiol. (Lung Cell Mol Physiol) 1991; 261:L370-L377.
37. Crystal RG. Lung collagen. Definition, diversity and development. Fed Proc. 1974; 33:2248-2255.
38. Hilfer SR, Rayner RM, Brown JW. Mesenchymal control of branching pattern in the fetal mouse lung. Tissue Cell. 1985; 17:523-538.
39. Shoemaker CT, Reiser KM, Goetzman BW, Last JA. Elevated ratios of type I/III collagen in the lungs of chronical ventilated neonates with respiratory distress. Pediatr Res. 1984; 18:1176-1180.
40. Kirk JME, Heard BE, Kerr I, Turner-Warwick M, Laurent GJ. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Coll Rel Res. 1984; 4:169-182.
41. Laurent GJ. Lung collagen: More than a scaffolding. Thorax. 1986; 41:418-428.
42. Nerlick AG, Nerlick ML, Muller PK. Patterns of collagen types and molecular structure of collagen in acute post-traumatic pulmonary fibrosis. Thorax. 1987; 42:863-869.
43. Bailey AJ, Sims TJ, Lelous M, Bazin S. Collagen polymorphism in experimental granulation tissue. Biophys Biochem Res Commun. 1975; 66:1160-1165.
44. Clore JN, Cohen IK, Diegelman RF. Quantitation of collagen types I & III during wound healing in rat skin. Proc Soc Exp Biol Med. 1979; 161:337-340.
45. Merkel JR, Di Paulo BR, Hallock GG, Rice DC. Type I & Type III collagen content of healing wounds in fetal and adult rats. Proc Soc Exp Biol Med. 1988; 187:493-497.
46. Schaffner F, Felig P, Trachtenberg E. Structure of the rat lung after protracted oxygen breathing. Arch Pathol. 1967; 83:99-105.
47. Sahabjami H. Nutrition and lung function. In: Massaro D, ed. Lung Cell Biology. In: Lenfant C, ed. Lung Biology in Health and Disease. Vol. 41. New York: Marcel Dekker, 1989;1247-1278.
48. Sekhon H, Thurlbeck WM. Lung cytokinetics following exposure to hypobaria and/or hypoxia, and undernutrition in growing rats. J Appl Physiol. 1995; 79:1299-1309.
49. Gorenflo M, Vogel M, Herbst L, Bassir C, Kattner E, Obladen M. Influence of clinical and ventilatory parameters on morphology of bronchopulmonary dysplasia. Pediatr Pulmonol. 1995; 19: 214-220.
50. Margraf LR, Tomashefsky JE, Bruce MC, Dahms BD. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis. 1991; 143:391-400.
51. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1995; 152:640-646.
52. Werthammer J, Brown ER, Neff RK. Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics. 1982; 69:301-304.